| scholarly article | Q13442814 |
| P2093 | author name string | Guillaume Dighiero | |
| P304 | page(s) | 278-284 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Hematology / the Education Program of the American Society of Hematology | Q26842068 |
| P1476 | title | CLL biology and prognosis |
| Q37694914 | Association of Bax Expression and Bcl2/Bax Ratio with Clinical and Molecular Prognostic Markers in Chronic Lymphocytic Leukemia |
| Q63441392 | Bortezomib induces different apoptotic rates in B-CLL cells according to IgVH and BCL-6 mutations |
| Q47607917 | Chronic Lymphocytic Leukemia Patient Clustering Based on Somatic Hypermutation (SHM) Analysis |
| Q36564936 | Clinical utility of assessing ZAP-70 and CD38 in chronic lymphocytic leukemia |
| Q80103632 | Comparison of methods for determining zeta-chain associated protein - 70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL) |
| Q37417442 | Cytokine Contents in Chronic Lymphocytic Leukemia: Association with ZAP70 Expression |
| Q59358761 | Definition of disease-progression risk stratification in untreated chronic lymphocytic leukemia using combined clinical, molecular and virological variables |
| Q54421951 | Expression profile of galectin-1 and galectin-3 molecules in different subtypes of chronic lymphocytic leukemia. |
| Q42660759 | Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKCα subversion induces up-regulation of PKCβII expression in B lymphocytes |
| Q36227244 | Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients |
| Q60197192 | Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia |
| Q51579239 | Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation. |
| Q33856215 | Multiplex ligation-dependent probe amplification versus multiprobe fluorescence in situ hybridization to detect genomic aberrations in chronic lymphocytic leukemia: a tertiary center experience |
| Q38268442 | Protein kinase C in cellular transformation: a valid target for therapy? |
| Q36843749 | Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia |
| Q34012864 | Relevance of stereotyped B-cell receptors in the context of the molecular, cytogenetic and clinical features of chronic lymphocytic leukemia |
| Q43282503 | Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide |
| Q33380747 | Successful long-term monotherapy with rituximab in a patient with chronic lymphocytic leukemia of the B-cell-lineage: a case report |
| Q43498163 | T/B ratio does not reflect levels of ZAP70 expression in clonal CLL B-cells due to ZAP70 overexpression in patient T-cells. |
| Q55077967 | The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index |
| Q87231114 | Treatment of chronic lymphocytic leukemia |
Search more.